Henry Younghwa Shin
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 23, 2023 | NIH | SBIR Phase II A Novel Small Molecule for the Prevention and Treatment of Diabetic Retinopathy | $783K | EXCITANT THERAPEUTICS LLC |
| Aug 18, 2022 | NIH | SBIR Phase II A Novel Small Molecule for the Prevention and Treatment of Diabetic Retinopathy | $871K | EXCITANT THERAPEUTICS LLC |
| Aug 11, 2021 | NIH | SBIR Phase I A Novel Small Molecule for The Prevention and Treatment of Age-Related Macular Degeneration | $277K | EXCITANT THERAPEUTICS LLC |
| Aug 31, 2020 | NIH | SBIR Phase I Evaluating therapeutic potential of a novel PPAR-a agonist for wet-AMD | $273K | EXCITANT THERAPEUTICS LLC |
| Aug 29, 2019 | NIH | SBIR Phase I A novel PPAR-a agonist for treating retinal inflammation and vascular hyper-permeability | $225K | EXCITANT THERAPEUTICS LLC |
Peer ranks
Federal funding#809
Awards as PI#417
Patents#273
Companies
- EXCITANT THERAPEUTICS LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.